DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Aplenzin (Bupropion Hydrobromide) - Published Studies

 
 



Aplenzin Related Published Studies

Well-designed clinical trials related to Aplenzin (Bupropion)

The DRD4 Exon III VNTR, Bupropion, and Associations With Prospective Abstinence. [2012]

A retrospective analysis of two randomized trials of bupropion for methamphetamine dependence: suggested guidelines for treatment discontinuation/augmentation. [2012]

Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in placebo-controlled clinical trials. [2012]

Effects of varenicline and bupropion on cognitive processes among nicotine-deprived smokers. [2012]

Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis. [2012]

Bupropion in the treatment of problematic online game play in patients with major depressive disorder. [2012]

Does acceptance and relationship focused behavior therapy contribute to bupropion outcomes? A randomized controlled trial of functional analytic psychotherapy and acceptance and commitment therapy for smoking cessation. [2011.12]

Pilot Randomized Clinical Trial of an SSRI vs Bupropion: Effects on Suicidal Behavior, Ideation, and Mood in Major Depression. [2011.10.12]

Neural correlates of antidepressant-related sexual dysfunction: a placebo-controlled FMRI study on healthy males under subchronic paroxetine and bupropion. [2011.08]

Varenicline versus Bupropion XL for Smoking Cessation in Older Adolescents: A Randomized, Double-Blind Pilot Trial. [2011.07.20]

Bupropion and restless legs syndrome: a randomized controlled trial. [2011.07]

Bupropion for smoking cessation in patients with acute coronary syndrome. [2011.06.27]

Genetic variants in the serotonin transporter influence the efficacy of bupropion and nortriptyline in smoking cessation. [2011.06.09]

Effect of bupropion treatment on brain activation induced by cigarette-related cues in smokers. [2011.05]

Bupropion sustained release added to group support for smoking cessation in schizophrenia: a new randomized trial and a meta-analysis. [2011.04.05]

Menstrual cycle phase at quit date and smoking abstinence at 6 weeks in an open label trial of bupropion. [2011.03.01]

Smoking cessation in primary care - a randomized controlled trial of bupropione, nicotine replacements, CBT and a minimal intervention. [2011.03]

Reversal of SSRI-induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double-blind, placebo-controlled and randomized study. [2011.03]

Bupropion SR and contingency management for adolescent smoking cessation. [2011.01]

Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial. [2011.01]

Reversal of SSRI-induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double-blind, placebo-controlled and randomized study. [2011]

The cost-effectiveness of aripiprazole as adjunctive therapy in major depressive disorder: Thai economic model. [2010.11]

Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo. [2010.11]

A randomized, double-blind, placebo-controlled study of the efficacy and safety of bupropion for treating hypoactive sexual desire disorder in ovulating women. [2010.09]

Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. [2010.08.21]

Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR. [2010.08]

Dopamine D4 receptor gene variation moderates the efficacy of bupropion for smoking cessation. [2010.07.27]

Effects of woohwangcheongsimwon suspension on the pharmacokinetics of bupropion and its active metabolite, 4-hydroxybupropion, in healthy subjects. [2010.07]

Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR-BMOD Trial. [2010.06.17]

A bupropion smoking cessation clinical trial for cancer patients. [2010.06]

Effects of bupropion on simulated demand for cigarettes and the subjective effects of smoking. [2010.04]

Double-blind, placebo-controlled evaluation of extended-release bupropion in elderly patients with major depressive disorder. [2010.04]

Bupropion and cognitive behavioral therapy for weight-concerned women smokers. [2010.03.22]

The impact of chronic bupropion on plasma cotinine and on the subjective effects of ad lib smoking: a randomized controlled trial in unmotivated smokers. [2010.02]

Preliminary effects of bupropion and the promoter region (HTTLPR) serotonin transporter (SLC6A4) polymorphism on smoking behavior in schizophrenia. [2010.01.30]

Reversal of SSRI-induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double-blind, placebo-controlled and randomized study. [2010.01.15]

Assessment of the effectiveness of sustained release Bupropion and intensive physician advice in smoking cessation. [2010.01]

Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. [2010]

Effects of bupropion on simulated demand for cigarettes and the subjective effects of smoking. [2010]

A bupropion smoking cessation clinical trial for cancer patients. [2010]

The effects of the adjunctive bupropion on male sexual dysfunction induced by a selective serotonin reuptake inhibitor: a double-blind placebo-controlled and randomized study. [2010]

Preliminary effects of bupropion and the promoter region (HTTLPR) serotonin transporter (SLC6A4) polymorphism on smoking behavior in schizophrenia. [2010]

Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR. [2010]

Comparison of combined bupropion and naltrexone therapy for obesity with monotherapy and placebo. [2009.12]

Impact of bupropion and cognitive-behavioral treatment for depression on positive affect, negative affect, and urges to smoke during cessation treatment. [2009.10]

Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder. [2009.09.30]

A randomized, controlled trial of bupropion sustained-release for preventing tobacco relapse in recovering alcoholics. [2009.07]

Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR. [2009.07]

Sustained-release bupropion for hospital-based smoking cessation: a randomized trial. [2009.06]

A preliminary trial: double-blind comparison of nefazodone, bupropion-SR, and placebo in the treatment of cannabis dependence. [2009.01]

A randomized trial of short psychotherapy versus sustained-release bupropion for smoking cessation. [2008.12]

A controlled trial of bupropion added to nicotine patch and behavioral therapy for smoking cessation in adults with unipolar depressive disorders. [2008.12]

Varenicline versus bupropion SR or placebo for smoking cessation: a pooled analysis. [2008.11]

Psychological mediators of bupropion sustained-release treatment for smoking cessation. [2008.09]

Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence. [2008.08.01]

Preliminary study of buprenorphine and bupropion for opioid-dependent smokers. [2008.07]

A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia. [2008.06.01]

A randomized, double-blind, placebo-controlled study of the effect of sustained-release bupropion on blood pressure in individuals with mild untreated hypertension. [2008.06]

Bupropion improves attention but does not affect impulsive behavior in healthy young adults. [2008.04]

A randomized controlled clinical trial of bupropion SR and individual smoking cessation counseling. [2008.04]

Smokers' response to combination bupropion, nicotine patch, and counseling treatment by race/ethnicity. [2008.01]

Bupropion hydrochloride versus placebo, in combination with cognitive behavioral therapy, for the treatment of cocaine abuse/dependence. [2008]

A Pilot Controlled Trial of Bupropion XL Versus Escitalopram in Generalized Anxiety Disorder. [2008]

Predictors of 12-month outcome in smokers who received bupropion sustained-release for smoking cessation. [2008]

Comparing the rapidity of response during treatment of major depressive disorder with bupropion and the SSRIs: a pooled survival analysis of 7 double-blind, randomized clinical trials. [2007.12]

Comparing gain- and loss-framed messages for smoking cessation with sustained-release bupropion: A randomized controlled trial. [2007.12]

Randomized, double-blind, placebo-controlled trial of 2 dosages of sustained-release bupropion for adolescent smoking cessation. [2007.11]

Well-designed clinical trials possibly related to Aplenzin (Bupropion)

Comparison of substance use milestones in cannabis- and cocaine-dependent patients. [2012]

Factors associated with smoking menthol cigarettes among treatment-seeking African American light smokers. [2011.12]

Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report. [2011.10]

Effectiveness of a stepped primary care smoking cessation intervention: cluster randomized clinical trial (ISTAPS study). [2011.09]

Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. [2011.07]

Predictors of smoking cessation among cancer patients enrolled in a smoking cessation program. [2011.06]

Culturally-tailored smoking cessation for American Indians: study protocol for a randomized controlled trial. [2011.05.18]

Treatment of nicotine dependence with Chantix (varenicline). [2011.05]

Treating heavy smokers in primary care with the nicotine nasal spray: randomized placebo-controlled trial. [2011.04]

General practice counseling for patients with chronic obstructive pulmonary disease to quit smoking: impact after 1 year of two complex interventions. [2011.04]

Smoker characteristics and smoking-cessation milestones. [2011.03]

Smoking history and motivation to quit in smokers with schizophrenia in a smoking cessation program. [2011.03]

Seizures during pegylated interferon and ribavirin therapy for chronic Hepatitis C: observations from the WIN-R trial. [2011.03]

Nicotine receptor partial agonists for smoking cessation. [2011.02.16]

Interventions for smokeless tobacco use cessation. [2011.02.16]

Anxiety diagnoses in smokers seeking cessation treatment: relations with tobacco dependence, withdrawal, outcome and response to treatment. [2011.02]

Design, baseline characteristics, and retention of African American light smokers into a randomized trial involving biological data. [2011.01.25]

Efficacy of antidepressants for dysthymia: a meta-analysis of placebo-controlled randomized trials. [2011]

Treating heavy smokers in primary care with the nicotine nasal spray: randomized placebo-controlled trial. [2011]

Smoking history and motivation to quit in smokers with schizophrenia in a smoking cessation program. [2011]

Nicotine receptor partial agonists for smoking cessation. [2010.12.08]

A multi-level analysis of non-significant counseling effects in a randomized smoking cessation trial. [2010.12]

Changes in health-related quality of life with smoking cessation treatment. [2010.09.30]

Smoking-induced change in intrasynaptic dopamine concentration: effect of treatment for Tobacco Dependence. [2010.09.30]

Subjective and objective effects of the novel triple reuptake inhibitor tesofensine in recreational stimulant users. [2010.07]

Mechanisms of change in extended cognitive behavioral treatment for tobacco dependence. [2010.06.01]

Adherence to treatment for tobacco dependence: association with smoking abstinence and predictors of adherence. [2010.06]

If you try to stop smoking, should we pay for it? The cost-utility of reimbursing smoking cessation support in the Netherlands. [2010.06]

Development of the Brief Wisconsin Inventory of Smoking Dependence Motives. [2010.05]

General practice counseling for patients with chronic obstructive pulmonary disease to quit smoking: Impact after 1year of two complex interventions. [2010.04.27]

Feasibility and acceptability of a phase II randomized pharmacologic intervention for methamphetamine dependence in high-risk men who have sex with men. [2010.04.24]

Prospective association of dopamine-related polymorphisms with smoking cessation in general care. [2010.04]

Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study. [2010.03]

The cost-effectiveness of an extended course (12+12 weeks) of varenicline compared with other available smoking cessation strategies in the United States: an extension and update to the BENESCO model. [2010.03]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012